BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 34601132)

  • 1. Genome editing in large animal models.
    Maynard LH; Humbert O; Peterson CW; Kiem HP
    Mol Ther; 2021 Nov; 29(11):3140-3152. PubMed ID: 34601132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Genome Editing and In Vivo Delivery.
    Ramirez-Phillips AC; Liu D
    AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review.
    Babačić H; Mehta A; Merkel O; Schoser B
    PLoS One; 2019; 14(2):e0212198. PubMed ID: 30794581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term stable reduction of low-density lipoprotein in nonhuman primates following in vivo genome editing of PCSK9.
    Wang L; Breton C; Warzecha CC; Bell P; Yan H; He Z; White J; Zhu Y; Li M; Buza EL; Jantz D; Wilson JM
    Mol Ther; 2021 Jun; 29(6):2019-2029. PubMed ID: 33609733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR technologies for the treatment of Duchenne muscular dystrophy.
    Choi E; Koo T
    Mol Ther; 2021 Nov; 29(11):3179-3191. PubMed ID: 33823301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy Development by Genome Editing of Hematopoietic Stem Cells.
    Koniali L; Lederer CW; Kleanthous M
    Cells; 2021 Jun; 10(6):. PubMed ID: 34198536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Progress in Therapeutic Gene Editing for Monogenic Diseases.
    Prakash V; Moore M; Yáñez-Muñoz RJ
    Mol Ther; 2016 Mar; 24(3):465-74. PubMed ID: 26765770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The delivery challenge: fulfilling the promise of therapeutic genome editing.
    van Haasteren J; Li J; Scheideler OJ; Murthy N; Schaffer DV
    Nat Biotechnol; 2020 Jul; 38(7):845-855. PubMed ID: 32601435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo somatic cell base editing and prime editing.
    Newby GA; Liu DR
    Mol Ther; 2021 Nov; 29(11):3107-3124. PubMed ID: 34509669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Therapeutic Genome Editing in China.
    Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y
    Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
    Zhang X; Wang L; Liu M; Li D
    Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9: targeted genome editing for the treatment of hereditary hearing loss.
    Farooq R; Hussain K; Tariq M; Farooq A; Mustafa M
    J Appl Genet; 2020 Feb; 61(1):51-65. PubMed ID: 31912450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of viral vectors as vehicles for DMD gene editing.
    Maggio I; Chen X; Gonçalves MA
    Genome Med; 2016 May; 8(1):59. PubMed ID: 27215286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 therapeutics for liver diseases.
    Aravalli RN; Steer CJ
    J Cell Biochem; 2018 Jun; 119(6):4265-4278. PubMed ID: 29266637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas gene therapy.
    Zhang B
    J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome editing for the reproduction and remedy of human diseases in mice.
    Hara S; Takada S
    J Hum Genet; 2018 Feb; 63(2):107-113. PubMed ID: 29180644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation.
    Dever DP; Porteus MH
    Curr Opin Hematol; 2017 Nov; 24(6):481-488. PubMed ID: 28806273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary Timeline of Genetic Delivery and Gene Therapy.
    Holl NJ; Lee HJ; Huang YW
    Curr Gene Ther; 2021; 21(2):89-111. PubMed ID: 33292120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR Genome Editing Technology and its Application in Genetic Diseases: A Review.
    Khatibi S; Sahebkar A; Aghaee-Bakhtiari SH
    Curr Pharm Biotechnol; 2021; 22(4):468-479. PubMed ID: 32564746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.